Login / Signup

Development of a risk prediction tool for patients with locally advanced and recurrent rectal cancer undergoing pelvic exenteration: protocol for a mixed-methods study.

Kilian G M BrownMichael SolomonKheng-Seong NgPaul SuttonCherry KohKathryn WhiteDaniel Steffensnull null
Published in: BMJ open (2023)
CRD42022351909.
Keyphrases
  • rectal cancer
  • locally advanced
  • neoadjuvant chemotherapy
  • phase ii study
  • randomized controlled trial
  • squamous cell carcinoma
  • clinical trial